Appropriate controls for data integrity were not exercised over computers used during PPQ lots.
Inspection Record
Kedrion BioPharma, Inc. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Written production and process control procedures were not followed in the execution ofthe various production and process control functions during the PPQ runs for RhoGAM S(H)4YW Incidences include, but are not limited to, the following: a.
Deviation investigations are not well documented.
Procedures designed to control microbiological contamination are not established.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.